Jump Trading’s Alder Biopharmaceuticals ALDR Stock Holding History

Jump Trading’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14,500	Closed	-$198K	–	694
2019 Q1	$198K	Buy	+14,500	New	+$188K	0.06%	350

Other funds holding ALDR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jump Trading's ALDR Position: Q2 2019 in Review

Jump Trading sold out of Alder Biopharmaceuticals (ALDR) in Q2 2019, closing a stake of 14,500 shares — an estimated $198K sold.

Jump Trading first reported a position in ALDR in Q1 2019 and held it in 1 quarter. The position peaked at $198K in Q1 2019. 127 funds tracked by Wall St. Rank hold ALDR as of Q2 2019.

Jump Trading reported no remaining Alder Biopharmaceuticals position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 14,500 Alder Biopharmaceuticals shares in Q2 2019, an estimated $198K.
Jump Trading first reported a position in Alder Biopharmaceuticals in Q1 2019 and held it in 1 quarter.
Jump Trading's Alder Biopharmaceuticals position peaked at $198K in Q1 2019.
127 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.